%0 Editorial
%T Toward Guideline-Directed Medical Therapy in Nephrology: Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease.
%A Zeitler EM
%A Mottl AK
%J Clin J Am Soc Nephrol
%V 17
%N 12
%D 12 2022
%M 36414317
%F 10.614
%R 10.2215/CJN.12401022